Free Trial
NYSE:ELAN

Elanco Animal Health Q1 2025 Earnings Report

Elanco Animal Health logo
$9.74 +0.28 (+2.90%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$9.70 -0.05 (-0.51%)
As of 05/2/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elanco Animal Health EPS Results

Actual EPS
N/A
Consensus EPS
$0.31
Beat/Miss
N/A
One Year Ago EPS
N/A

Elanco Animal Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.17 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elanco Animal Health Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Wednesday, May 7, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Elanco Animal Health Earnings Headlines

Leerink Partnrs Analysts Lower Earnings Estimates for ELAN
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Elanco price target lowered to $13 from $16 at BofA
See More Elanco Animal Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elanco Animal Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elanco Animal Health and other key companies, straight to your email.

About Elanco Animal Health

Elanco Animal Health (NYSE:ELAN), an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

View Elanco Animal Health Profile

More Earnings Resources from MarketBeat